Research
Introduction - Max Research Centre
At Max Healthcare (MHC), the Office of Research (OOR) stands as a beacon of support and guidance, fostering a vibrant research culture and serving as the primary gateway for forging new research collaborations. Committed to elevating healthcare through robust research endeavours, Max Healthcare has placed a strong emphasis on cultivating research excellence and nurturing an academic milieu.
Since its establishment in 2005, the OOR has steadfastly pursued a singular mission: to enhance the quality, quantity, and efficacy of translating groundbreaking scientific advancements into tangible clinical benefits for our patients. Bolstered by a dedicated team, the OOR provides comprehensive support to researchers embarking on endeavours ranging from fundamental scientific inquiries to clinical trials, offering operational, administrative, scientific, academic, and technological assistance.
Max Healthcare has garnered a distinguished reputation both nationally and internationally in the realm of research, marked by a steady increase in clinical trials, research studies, and funded grant initiatives year after year.
Our Vision
Our aspiration is to emerge as a preeminent leader in healthcare research and innovation on the national stage. Through our contributions to scientific knowledge, alleviation of disease burden, enhancement of healthcare delivery systems, and fortification of research capabilities, we endeavour to shape the future of healthcare.Our Mission
- Conduct novel and impactful studies.
- Establish a culture of research excellence across Max Healthcare units.
- Foster the development of specialised research groups.
- Deliver top-tier clinical research services for clinical trials.
- Cultivate educational programmes focused on research.
- Nurture a culture of innovation.
- Forge partnerships focusing on sharing technology and research infrastructure.
- Provide a platform for the professional growth of clinical faculty.
- Contribute to enhancing clinical and health outcomes for patients.
- Identify and explore opportunities for cost-effective and safe healthcare delivery systems.
Dr. Sandeep Budhiraja’s Message

It is with great pride that I share with you the remarkable strides we have made in the realm of medical research and education over the past year.
Max Healthcare has always been committed to advancing medical knowledge, fostering innovation, and nurturing the next generation of healthcare professionals. Our dedication to research and academics has been instrumental in shaping the landscape of healthcare delivery and improving patient outcomes.
Our drive for excellence is built on research. We have continued to foster a culture of scientific inquiry, encouraging our clinicians and researchers to explore new frontiers and push the boundaries of medical science. Through our robust research infrastructure and collaborations with renowned academic institutions, we have been able to initiate and participate in over 110+ clinical trials and 23 ongoing research studies covering a diverse range of therapeutic areas. These endeavours not only contribute to the advancement of medical knowledge but have also paved the way for breakthrough treatments and therapies that have positively impacted the lives of our patients. We are proud to have established new collaborations this year with Ashoka University and Pfizer Inc. to promote our research efforts.
Our engagement with Ashoka University has commenced with key projects in oncology, antimicrobial resistance and diabetes. Pfizer Inc helps strengthen Real World Evidence studies and capacity building in infectious diseases and rheumatology. Our new collaborations with IIT Bombay, IIT Delhi, BITS Pilani, and IIIT Delhi bring expertise in data science, computational biology, AI/ML for big data analytics and predictive modelling for diagnostic and prognostic benefits.
Our emphasis on academic excellence complements our dedication to research. We truly believe that providing excellent health care requires a foundation built on education and training. Max Healthcare has kept up its investment in academic initiatives, offering our healthcare personnel opportunities for career advancement and lifelong learning. We provide training programmes, fellowships, and continuing medical education courses through partnerships with prestigious medical colleges and universities, enabling our physicians the training and tools they require to deliver the highest level of care to their patients. Our new affiliation with the Academy of Scientific and Innovative Research (AcSIR) allows Max as a private provider to offer degree programs such as Master's in Public Health and PhD. In collaboration with DBT, the Regional Centre for Biotechnology, we have initiated an MSc Clinical Research degree program.
I am confident our continued efforts in research and academics, coupled with finding strategic partnerships, will create an ecosystem to deliver high-quality clinical excellence and bring best-in-class services to our patients.
Dr. Sandeep Budhiraja
Group Medical Director
Dr. Vinita Jha's Message

I am delighted to highlight the dedication and efforts of our clinicians, researchers, faculty, students, advisors, collaborators and management across our network. Over the past two years, the Office of Research and has secured grants from prestigious national and international agencies—including NIHR UK, ICMR, DBT, INSA, BIRAC, Pfizer and Ashoka University—to support twenty-nine ongoing projects in high-priority areas such as diabetes, cardiovascular health, infectious diseases and antimicrobial resistance. These awards, drawn from both public and industry sources, have underpinned public-health studies, real-world evidence initiatives, capacity-building programmes and cutting-edge digital-health solutions, all aligned with the government’s vision for robust, high-quality data.
Within our clinical network, we have completed over 650+ trials to date, are currently implementing 30 grant-funded research projects, and are placing special emphasis on Phase II and Phase IV investigations. Our scholarly output remains a key performance measure, as our clinicians have contributed over 2,800 articles to reputable, indexed journals, reflecting our commitment to knowledge generation and dissemination. At the same time, we have formalised new strategic partnerships with Ashoka University, Pfizer Inc., AcSIR, IIT Bombay, IIT Delhi, BITS Pilani, IIIT Delhi and RCB, creating an ecosystem in which each partner’s expertise is valued and leveraged for future endeavours.
On the academic front, we enrol more than 12,000 students in our Diplomate of National Board (DNB), Master's in Emergency Medicine (MEM) and Internal Medicine Training (IMT) programmes annually. Our Lifesaver courses—including AHA’s BLS, ACLS and PALS certifications, as well as Max Life Support—trained over 8,500 trainees in FY 25. We also launched a two-year Master’s in Public Health in conjunction with AcSIR.
I invite each of you to engage actively with these research and academic initiatives, to share your insights and to collaborate across disciplines. Together, we will continue to drive innovation, advance medical knowledge and deliver transformative patient care.
Dr Vinitaa Jha
Director - Research and Academics
Research at a Glance
Funded Research Projects
Completed Clinical Trials
On-going Clinical Trials
Publications
Collaboration & Partnerships with Research Institute
International Partners and Collaborators
- Imperial College London
- Karolinska Institute
- Monash University
- Deakin University
- BRAC University
- Aston University
- United Imaging Healthcare
Domestic Partners and Collaborators
- Indian Institute of Technology, Bombay
- Pfizer
- BITS Pilani
- Indian Institute of Technology, Delhi
- Indraprastha Institute of Information Technology, Delhi
- Ashoka University
- Regional Centre for Biotechnology
- Academy of Scientific and Innovative Research (AcSIR)
- Mazumdar Shaw Medical Foundation
- Madras Diabetes Research Foundation
- Institute of Genomics & Integrative Biology
- National Centre for Biological Science (NCBS)
- Tata Institute for Genetics and Society (TIGS)
- Rajiv Gandhi Centre for Biotechnology
Funding Organisations
- National Institute for Health and Care Research (NIHR)
- National Institutes of Health (NIH)
- UK Research and Innovation (UKRI)
- European Union Horizon
- Wellcome Trust
- UK Aid Direct
- Indian Council of Medical Research (ICMR)
- Biotechnology Industry Research Assistance Council
Research and Academic Book
Max Medical Journal
Original research articles and compelling case reports, reflecting our collective pursuit of clinical excellence and evidence-based insights.
Max Medical Minds
Our doctors go beyond treatment to push the boundaries of medical science through research. Our doctors go beyond treatment to push the boundaries of medical science through research.
More about Research
CLINICAL TRIALS
The CTSO support the whole Process of CTs starting from feasibility to closures. Provide CRC & Project manager support...
INVESTIGATOR INITIATED
MHC encourages investigator initiates studies (IIS) to strengthen and contribute to evidence based research. IIS are...
PUBLIC HEALTH RESEARCH
Public Health research plays an important role in aiding, preventing health hazards and ensures far more effective, less expensive...
RESEARCH GRANTS
The grants office will support in identifying grant areas and institutions, enable grant writing and focus on maximizing...
ACADEMIC DATA RESEARCH
With the regulatory landscape for clinical research in India witnessing an overhaul in early 2013, has provided an impetus...
BIOBANK
The biobank shall be biorepository to store biological samples (usually human) for use in research and shall become...
GOVERNANCE
In view of compliance as per the national & international guidelines for conduct of any kind of clinical research programs...
MOLECULAR LAB
Molecular diagnostics has been evolving over the years in India. Many organizations both in the private and government sector...
PUBLICATIONS
Max Healthcare has been encouraging its medical and para medical staff including academicians and researchers to...
